Advanced Search
Contact | Corporate | Help

BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer

Sponsors:
  • M.D. Anderson Cancer Center
  • Eli Lilly and Company
  • Genentech
  • ImClone LLC
Phases:
  • Phase II
IndicationsAcronym:
  • Lung Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Carboplatin
  • Drug: Pemetrexed
  • Drug: Bevacizumab
  • Drug: Cetuximab
  • Drug: Cixutumumab
Enrollment:
300

Additional information about NCT01263782.


SourceSolution © 2008-2012